Robert A Volkmann

This inventor holds 74 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 12 EPO patents, primarily in NMDA Receptor Modulators (CPC class C07D). Top assignees: Pfizer Corporation, Cadent Therapeutics, Inc., Novartis Ag. Active years: 1984-2025.

USPTO Granted Patents = 74 (Patent Applications = 14)

% Patents Active = 94.6

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 12 (Patent Applications = 21)

Average Co-Inventor Count = 2.3

ph-index = 10

Forward Citations = 336(Granted Patents)

Forward Citations (Not Self Cited) = 256(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Ledyard, CT (US) (1984 - 1994)
New York, NY (US) (2000)
Mystic, CT (US) (1989 - 2023)
Groton, CT (US) (1988 - 2024)

Company Filing History:

Cadent Therapeutics, Inc.

Lixte Biotechnology, Inc.

Luc Therapeutics, Inc.

patents

10. 1 out of 51

Buck Institute for Research on Aging

patents

11. 1 out of 1

Krouzon Pharmaccuticals, Inc.

patent

12. 1 out of 1

Napa Therapeutics Limited

where one patent can have more than one assignee

Years Active: 1984-2025

Loading Chart...

Areas of Expertise:

NMDA Receptor Modulators

Peptide Conjugates

Cytotoxins

Prodrugs

Heteroaryl Amides

Negative Modulators

Microtubule-Targeting Agents

Thienopyrimidinone

Oxabicycloheptane

Pain Treatment

Allosteric Inhibitors

Data Mining

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509451 - Heteroaryl amide inhibitors of CD38 (2025-12-30),

2. 12427157 - Methods for treatment of diseases involving acidic or hypoxic diseased tissues (2025-09-30),

3. 12410262 - Peptide conjugates of cytotoxins as therapeutics (2025-09-09),

4. 12358929 - NMDA receptor modulators and uses thereof (2025-07-15),

5. 12234212 - Peptide conjugates of microtubule-targeting agents as therapeutics (2025-02-25),

6. 12162890 - Heteroaromatic NMDA receptor modulators and uses thereof (2024-12-10),

7. 12161624 - Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B (2024-12-10),

8. 12145909 - N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B (2024-11-19),

9. 11866444 - Oxabicycloheptane prodrugs (2024-01-09),

10. 11807650 - NMDA receptor modulators and uses thereof (2023-11-07),

11. 11648253 - Thienopyrimidinone NMDA receptor modulators and uses thereof (2023-05-16),

12. 11634508 - Peptide conjugates of cytotoxins as therapeutics (2023-04-25),

13. 11555019 - Peptide conjugates of microtubule-targeting agents as therapeutics (2023-01-17),

14. 11542264 - Heteroaromatic NMDA receptor modulators and uses thereof (2023-01-03),

15. 11541057 - Thienopyrimidinone NMDA receptor modulators and uses thereof (2023-01-03),

Title: The Innovative Journey of Robert A Volkmann

Introduction: Robert A Volkmann, a talented inventor hailing from Mystic, CT (US), has made significant contributions to the world of technology through his groundbreaking inventions.

Latest Patents: Robert A Volkmann's latest patents include cutting-edge technologies in the fields of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Robert A Volkmann has established himself as a pioneer in the innovation industry, with multiple successful ventures and patents to his name. His dedication to pushing the boundaries of what is possible has led to numerous breakthroughs that have positively impacted society.

Collaborations: Throughout his career, Robert A Volkmann has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Robert A Volkmann's passion for innovation, coupled with his technical expertise, has solidified his position as a respected inventor in the technology sector. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.